4.6 Article

Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Covid-19: Pathophysiology; Mechanism of Transmission and Possible Molecular Drug Target for Management

Asis Bala et al.

Summary: COVID-19, caused by SARS-CoV-2, is a potentially fatal disease of global public health concern. The understanding and exploration of transmission pathways and molecular drug targets are ongoing, with countries implementing social distancing and lockdown measures. The main transmission routes include respiratory droplets and fecal-oral transmission, with potential treatment strategies involving immunoenhancement therapy and drug combinations.

CURRENT MOLECULAR PHARMACOLOGY (2021)

Article Medicine, Research & Experimental

BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers

Magali Noval Rivas et al.

Summary: In this study of healthcare workers, those with a history of BCG vaccination had lower seroprevalence of anti-SARS-CoV-2 IgG and reported fewer COVID-19-related symptoms compared to those without BCG vaccination. This suggests a potential protective effect of BCG vaccination against SARS-CoV-2 infection, warranting further large-scale clinical trials for confirmation.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Review Pharmacology & Pharmacy

COVID-19 vaccines: The status and perspectives in delivery points of view

Jee Young Chung et al.

Summary: The COVID-19 pandemic, caused by SARS-CoV-2, has highlighted the urgent need for efficient and safe vaccines to prevent the spread of the virus and restore social and economic activities through mass immunization. Various vaccine candidates and alternative therapies are under development to combat the challenges presented by the disease.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Genetics & Heredity

Epidemiological transcriptomic data supports BCG protection in viral diseases including COVID-19

Abhay Sharma

Summary: An integrative analysis of existing data suggests that BCG vaccine may induce long-lasting transcriptomic changes that mimic viral infections and oppose them by modulating antiviral defense responses. These durability and mechanistic insights highlight potential safety concerns associated with the indiscriminate use of the vaccine in COVID-19.
Article Immunology

Multidrug-resistant tuberculosis patients expressing the HLA-DRB1*04 allele, and after treatment they show a low frequency of HLA-II plus monocytes and a chronic systemic inflammation

Ranferi Ocana-Guzman et al.

Summary: The study found that multidrug-resistant tuberculosis (MDR-TB) patients show different immune responses and levels of inflammation during anti-tuberculosis treatment compared to drug-sensitive TB patients, and may be associated with specific HLA alleles.

MICROBIAL PATHOGENESIS (2021)

Review Immunology

COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations

Qian He et al.

Summary: The world is facing the second wave of the COVID-19 pandemic, with a higher intensity than the first wave of early 2020. Multiple COVID-19 vaccine candidates have been developed and are undergoing clinical testing to rapidly respond to the global pandemic. Evaluating and defining effective vaccine candidates is crucial for prioritizing vaccination programs against COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Genetics Insight for COVID-19 Susceptibility and Severity: A Review

Ingrid Fricke-Galindo et al.

Summary: COVID-19 presents a broad spectrum of clinical manifestations, with genetic variants in HLA genes, cytokine genes, and ACE2/TMPRSS2 genes being potentially related to susceptibility and severity. Further research on the identified risk-genes and studies in different populations are needed.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation

Lucy G. Thorne et al.

Summary: SARS-CoV-2 infection leads to broad-spectrum immunopathological diseases, exacerbated by inflammatory co-morbidities. Research shows that the virus replicates rapidly in lung epithelial cells and triggers a robust innate immune response, affecting macrophage activation through inflammatory mediators produced during infection. Further exacerbation of the local inflammatory environment occurs when macrophages or epithelial cells are primed with exogenous inflammatory stimuli.

EMBO JOURNAL (2021)

Review Immunology

COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials

Wenping Gong et al.

Summary: This study reviewed the concept and mechanisms of trained immunity induced by the BCG vaccine and presented details of current BCG vaccine clinical trials. The advantages of the BCG vaccine may be essential in overcoming the challenges faced by COVID-19 vaccines.

EXPERT REVIEW OF VACCINES (2021)

Article Cell Biology

Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients

Cristina Bergamaschi et al.

Summary: Early responses to vaccination play a crucial role in shaping both humoral and cellular protective immunity. This study characterizes cytokine and chemokine responses after the first and second dose of the BNT162b2 mRNA vaccine, highlighting the potential for biomarkers like IL-15 and IFN-gamma in predicting humoral immunity development. In previously COVID-19-infected individuals, a single vaccination can trigger strong cytokine induction and antibody responses similar to those seen in naive individuals upon booster vaccination, with implications for future public health recommendations.

CELL REPORTS (2021)

Article Immunology

Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection

Jose Javier Morales-Nunez et al.

Summary: The study evaluated the efficacy of the Pfizer-BioNTech vaccine in producing neutralizing antibodies, finding 100% production after the second dose in both groups and well-tolerated side effects. Additionally, a single dose of the vaccine may be sufficient for immunity in individuals with prior COVID-19 infection, with possible signs of immunosenescence.

VACCINES (2021)

Article Immunology

Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination

Lisa Mueller et al.

Summary: The study compared antibody responses to the BNT162b2 COVID-19 vaccine in young vaccinees below 60 and elderly vaccinees over 80. The elderly group had lower antibody titers and a lower frequency of neutralizing antibodies post-vaccination, indicating a potential need for closer monitoring or different vaccination strategies for this population.

CLINICAL INFECTIOUS DISEASES (2021)

Review Immunology

Effects of interleukin-2 in immunostimulation and immunosuppression

Jonathan G. Pol et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Medical Laboratory Technology

Cytokine storm induced by SARS-CoV-2

Peipei Song et al.

CLINICA CHIMICA ACTA (2020)

Review Environmental Sciences

Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy

Mahesh Jayaweera et al.

ENVIRONMENTAL RESEARCH (2020)

Review Biotechnology & Applied Microbiology

BCG vaccine: a hope to control COVID-19 pandemic amid crisis

Yashpal Singh Malik et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)

Review Immunology

Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines

Katie L. Flanagan et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins

Carina Conceicao et al.

PLOS BIOLOGY (2020)

Article Multidisciplinary Sciences

Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses

Janine Hensel et al.

SCIENTIFIC REPORTS (2020)

Review Immunology

Back to the Future: Lessons Learned From the 1918 Influenza Pandemic

Kirsty R. Short et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)

Article Multidisciplinary Sciences

Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered

Christopher Dye

JOURNAL OF THE ROYAL SOCIETY INTERFACE (2013)

Review Oncology

Role of bacillus Calmette-Guerin in the treatment of advanced melanoma

John H. Stewart et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2011)

Review Geriatrics & Gerontology

Immunity and ageing in man

Graham Pawelec

EXPERIMENTAL GERONTOLOGY (2006)